Place it in its market
Seven layers of its region's market — rates, credit, stress, liquidity, regime, breadth and sectors — with historical precedents. Public example: Apple and ASML.
See how Context works →On the price, the facts of the public record●Results filed
With an account, also○dividends▲splits◌next earningswith an account
End-of-day prices provided by Twelve Data · One close per session; the series does not update during the trading day.
Latest on record
The most recent facts, as filed.
Up to three of the most recent, checkable facts already loaded on this page, each linked to its source.
- Aug 14, 2026Quarterly report · 10-QFiled by the company itself.Open the filing ↗
- Aug 14, 2026Material event · 8-KFiled by the company itself.Open the filing ↗
- Jul 30, 2026Material event · 8-KFiled by the company itself.Open the filing ↗
In numbers
What this profile holds, counted.
Closes · 1 year250
SEC filings on record76616 flagged findings
Reported transactions (Form 4)80since Jun 1, 2023 · and 2 other holdings
Corporate events (8-K)30since Dec 23, 2019
What the record says
Description, identity and filings, each with its source.
Every block cites its source. The colour of a finding marks its category — which document, who filed it — not how much it matters.
Identity
Formerly traded as CARA.
Regulatory history
Topics detected in its SEC reports, with the original excerpt.
Each topic is assigned by a classifier over the full filing; the excerpts show where it was detected and are not always enough to verify it. Open the filing to read it in full.
- 2026-05-08share offering or dilution eventrecentOpen filing ↗“…or liabilities as of March 31, 2026 and December 31, 2025. There were no transfers between Levels during the periods presented.…”
+1 more passage from the same document
- “…the periods presented. The unrealized loss on the Company’s short-term investments for the three months ended March 31, 2026 and the…”
- 2026-05-08merger or acquisition eventrecentOpen filing ↗“…trial of TTI-101 in idiopathic pulmonary fibrosis (IPF) and concluded that the study did not meet its goals. The Company is…”
+1 more passage from the same document
- “…anticipated in these forward-looking statements as a result of various factors. Factors that could cause or contribute to these…”
- 2026-05-01capital return (buybacks/dividends)recentOpen filing ↗“…Warrants From time to time, we may offer and sell up to $200,000,000 of any combination of shares of our common stock, shares…”
- 2026-05-01merger or acquisition eventrecentOpen filing ↗“…We were originally incorporated in Delaware in July 2004 as Cara Therapeutics, Inc. (“Cara”). On April 15, 2025 (the “Closing…”
+1 more passage from the same document
- “…Inc. (“Cara”). On April 15, 2025 (the “Closing Date”), Cara, now known as Tvardi Therapeutics, Inc., completed its previously…”
- 2026-05-01reverse splitrecentOpen filing ↗“…which Merger Sub merged with and into Legacy Tvardi, with Legacy Tvardi surviving the merger as a wholly owned subsidiary of Cara…”
+1 more passage from the same document
- “…Tvardi, with Legacy Tvardi surviving the merger as a wholly owned subsidiary of Cara (the “Merger”). Also on April 15, 2025, Cara…”
Original excerpts from SEC filings, untranslated. Not advice and not a prediction.
Reverse splits in 5 years
2 reverse splits in 5 years (1:12 on Dec 31, 2024, 1:3 on Apr 16, 2025) · 1:36 cumulative
The other times: of 247 securities that repeated a reverse split in 5 years, a year later the median was worth 0.10× the price on the day of the split; 189 lost more than half and 21 rose (243 with a price a year later).
Our own series, not the whole market: based on the splits we have on record (provider and SEC); an unrecorded one does not count. Historical distribution, not a prediction.
The 25 most recent filings (of 766)
Every SEC filing, newest first, with what it is. Below, each type with its own explanation.
- Aug 14, 2610-Q ↗Quarterly report
- Aug 14, 268-K ↗Current report · Results
- Jul 30, 268-K ↗Current report · Communication to the market
- Jul 17, 268-K ↗Current report · Other events
- Jul 17, 26424B5 ↗Securities offering
- Jul 7, 268-K ↗Current report · Communication to the market
- Jun 11, 268-K ↗Current report · Shareholder vote results
- May 8, 26POS AM ↗Securities offering
- May 8, 26CORRESP ↗Correspondence with the SEC
- May 8, 2610-Q ↗Quarterly report
- May 8, 268-K ↗Current report · Results
- May 7, 26UPLOAD ↗Correspondence with the SEC
- May 1, 26S-3 ↗Securities offering
- Apr 23, 26DEFA14A ↗Shareholder meeting and votes
- Apr 23, 26DEF 14A ↗Shareholder meeting and votes
- Apr 1, 26424B3 ↗Securities offering
- Mar 31, 2610-K ↗Annual report
- Mar 31, 268-K ↗Current report · Results
- Mar 6, 26424B3 ↗Securities offering
- Mar 6, 268-K ↗Current report · Other events
766 filings on record, the oldest from Nov 1, 13.
Listing the 25 most recent filings of the 766 on record.
51523
- Dec 18, 25A senior executive left or was appointed8-K 5.02 ↗
- Jul 14, 25A senior executive left or was appointed8-K 5.02 ↗
- May 13, 25Auditor change filing (8-K Item 4.01)+2 more in the same filing8-K 4.01 ↗
- May 13, 25Completed an acquisition or disposal+1 more in the same filing8-K/A 2.01 ↗
- Apr 15, 25Entered a material agreement+10 more in the same filing8-K 1.01 ↗
- Dec 18, 24Entered a material agreement+4 more in the same filing8-K 1.01 ↗
- Nov 22, 24Listing notice (8-K 3.01)+1 more in the same filing8-K 3.01 ↗
- Aug 1, 24Listing notice (8-K 3.01)8-K 3.01 ↗
- Jun 18, 24Restructuring plan with committed costs8-K 2.05 ↗
- Mar 22, 24A senior executive left or was appointed8-K 5.02 ↗
- Feb 2, 24Listing notice (8-K 3.01)8-K 3.01 ↗
- Jan 22, 24Restructuring plan with committed costs+3 more in the same filing8-K 2.05 ↗
12 older filings not shown · The record reaches back to Feb 7, 14.
Corporate events are tracked from 2004-08-23, when the SEC renumbered 8-K items. Earlier filings use an incompatible numbering and are not classified here.
Schedule 13D: stake and stated purpose
Filed by holders above 5% of a share class who cannot use the short form. It includes the investor's stated purpose: read it before assuming they seek influence.
- Vifor (International) Ltd.2.2%Apr 15, 25SCHEDULE 13D/A ↗2 co-filers on this document — the figure is the largest single stake, not their sum. · 1 earlier filing
Schedule 13G: short-form filing
The short form, for holders who meet specific requirements: institutional investors, passive investors without a control purpose, or exempt investors. Asset managers and index funds usually file it.
- Sporos Bioventures LLC8.9%Apr 15, 25SCHEDULE 13G ↗
- Solas Tvardi Sidecar LLC8.1%Apr 15, 25SCHEDULE 13G ↗3 co-filers on this document — the figure is the largest single stake, not their sum.
- Slate Path Capital LP7.5%Jun 30, 25SCHEDULE 13G ↗2 co-filers on this document — the figure is the largest single stake, not their sum.
- David J. Tweardy7.0%Apr 15, 25SCHEDULE 13G ↗
- Ronald A. DePinho4.5%Dec 31, 25SCHEDULE 13G/A ↗2 earlier filings
show one more holderhide
- Samuel D. Tweardy3.4%Jul 7, 25SCHEDULE 13G/A ↗1 earlier filing
Structured 13D/G data starts 2023-12, when the SEC moved these filings to a machine-readable format. Earlier filings exist but are not parsed here.
- Feb 28, 25Sell$776Scott TerrillionSEC'Y; CHIEF COMPLIANCE & G.C.↗
- Feb 28, 25Sell$3KChristopher PosnerPRESIDENT AND CEO↗
- Feb 4, 25Sell$2KChristopher PosnerPRESIDENT AND CEO↗
- Nov 4, 24Sell$1KChristopher PosnerPRESIDENT AND CEO↗
- Aug 1, 24Sell$1KChristopher PosnerPRESIDENT AND CEO↗
- May 2, 24Sell$3KChristopher PosnerPRESIDENT AND CEO↗
- Apr 5, 24Sell$2KScott TerrillionSEC'Y; CHIEF COMPLIANCE & G.C.↗
- Apr 5, 24Sell$2KJoana GoncalvesCHIEF MEDICAL OFFICER↗
- Feb 29, 24Sell$3KJoana GoncalvesCHIEF MEDICAL OFFICER↗
- Feb 29, 24Sell$5KChristopher PosnerPRESIDENT AND CEO↗
- Feb 29, 24Sell$3KScott TerrillionSEC'Y; CHIEF COMPLIANCE & G.C.↗
- Feb 8, 24Sell$19KChristopher PosnerPRESIDENT AND CEO↗
There are 6 more transactions in this stretch.
Stock compensation, tax and giftsshow the 22 other transactionshide
Stock compensation, tax withholding, option exercises and gifts. They are listed separately and are not included in the purchase and sale totals. The type describes the transaction, not the filer's intent.
- Jul 7, 25Otheramount n/aSamuel David Tweardy↗
- Apr 15, 25Otheramount n/aWALLACE L HALL JR↗
- Apr 15, 25Otheramount n/aWALLACE L HALL JR↗
- Apr 15, 25Compensationamount n/aShaheen Wirk↗
- Apr 15, 25Compensationamount n/aShaheen Wirk↗
- Apr 15, 25Compensationamount n/aWALLACE L HALL JR↗
- Apr 15, 25Compensationamount n/aWALLACE L HALL JR↗
- Apr 15, 25Otheramount n/aShaheen Wirk↗
- Apr 15, 25Otheramount n/aShaheen Wirk↗
- Jun 4, 24Compensationamount n/aMARTIN VOGELBAUM↗
- Jun 4, 24Compensationamount n/aSusan Shiff Ph.D.↗
- Jun 4, 24Compensationamount n/aJeffrey L. Ives↗
- Jun 4, 24Compensationamount n/aMoltke Lisa von↗
- Jun 4, 24Compensationamount n/aHelen M Boudreau↗
- Feb 1, 24Compensationamount n/aChristopher PosnerPRESIDENT AND CEO↗
- Feb 1, 24Compensationamount n/aFrederique Menzaghi Ph.D.CHIEF SCIENTIFIC OFF,SVP-R&D↗
- Feb 1, 24Compensationamount n/aJoana GoncalvesCHIEF MEDICAL OFFICER↗
- Feb 1, 24Compensationamount n/aRyan D MaynardCHIEF FINANCIAL OFFICER↗
- Feb 1, 24Compensationamount n/aScott TerrillionSEC'Y; CHIEF COMPLIANCE & G.C.↗
- Jun 1, 23Compensationamount n/aMARTIN VOGELBAUM↗
- Jun 1, 23Compensationamount n/aHARRISON M BAINS JR↗
- Jun 1, 23Compensationamount n/aJeffrey L. Ives↗
The full record holds 57 transactions and goes back to Aug 9, 22.
Its sector and its market
Tvardi Therapeutics, Inc. among Health Care companies
The profile shows what is on record. Context and Radar place the company among those of its sector and region.
Browse its neighbours
Other Health Care companies
With an account you also get
- The four engines — growth, trend, risk and context — each with its word and its score.
- The risk band and the sector phase.
- The company's fundamentals and accounts.
- Watchlist: your list of companies, with the «since you follow it» figure.
The research continues
The profile tells the story. The market sets the scene.
From Tvardi Therapeutics, Inc., the path continues in the other areas. Each one is shown with its own example, named in its step.
See what deserves a closer look
Every morning Radar screens the covered companies through a lens and explains why each candidate made the list. Public example: the lists from Aug 11, 2026.
See how Radar works →Keep the why
Follow Tvardi Therapeutics, Inc. in the Watchlist and review what changed since you added it: context, notices and filings. Written theses are coming soon. Public example: Apple.
See an example review →
Coverage
What sits behind this page.
Where each figure comes from and how far it reaches.
- Prices
- End-of-day closes provided by Twelve Data. One close per session; not real time. Closes adjusted for splits.
- Series quality
- Series with incidents in the period; the chart shows what could be kept.
- SEC records
- 766 documents on file, from Nov 1, 2013 to Aug 14, 2026.
- Company description
- No description available.
- This page
- Generated on Oct 19, 2026; refreshed through the day.
Start at your own pace
Explore first. Go deeper with access.
Every company's public profile is open. The full reading — context, Radar, watchlist — is inside, in an invitation-only beta.
Compare plans →- No account
This profile for every company we cover: closing prices with the record's facts on the curve, the SEC file in plain language, insider trades included, and links to its sector and exchange.
- Pro
What matters today, with its reason, is free with an account. Pro adds, in the profile, each company's notices and their explanation and the analysis of its insiders; in Radar, all the lenses, which notice each candidate carries, filters by notice type and «no dilution», and the cycle cohort filter; and in Watchlist, more companies and notice changes with their reason.
- Pro+
Adds the Lab: test a hypothesis on comparable cohorts before reusing it; and bring your lenses to Radar.
Are the prices real time?
No. It is one close per session, from the provider and with the date shown on the profile; it does not update during the trading day.
Which SEC documents appear here?
Those filed with the SEC by the company, its insiders and its major shareholders, within our coverage: periodic reports (10-K, 10-Q, 20-F), material events (8-K), proposed sale notices (Form 144), insider transactions (Form 4) and stakes above 5% (13D/13G). Each links to the original on EDGAR.
Why does a European company show no SEC records?
It depends on the company: some European issuers file a 20-F or 6-K with the SEC and others don't. The profile shows whatever is on record; when there is nothing, it says so rather than guessing why. Europe does not yet have a common filing archive like EDGAR in the United States. The EU will open its own, ESAP, in July 2027 (managers' transactions arrive in January 2028), and we plan to add it once it is available.
Before forming a view on a company,
read what is on record.
One close per session. The record in plain language. Its sector and its market one link away. Your judgment when deciding.